ISSN 0303-5212
 

Original Research
Online Published: 25 Nov 2014
 
RMJ. 2014; 39(4): 421-424


Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.

Imran Memon, Atif Javed, Abdul Jabbar Pirzada, Aziz Abdullah, Sajid Ali, Syed Farhan Ahmed.


Abstract
Objective: To evaluate the efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.
Methodology: This randomized clinical trial was conducted at the Department of Urology, Liaquat National Hospital, Karachi, from May 3, 2012 to September 20, 2013. Seventy patients of BPH with irritative (overactive bladder) symptoms were included in the study and were divided into two groups with 35 patients in each group; one group receiving Alfuzosin with Tolterodine and other Alfuzosin only. Both the groups were compared for efficacy with decrease in International Prostatic symptom scoring of > 3 points from the baseline at 12 wks.
Results: Patients receiving Alfuzosin with Tolterodine, 27 (77.1%) reported symptomatic improvement whereas only 28.6% of patients improved with Alfuzosin only (p=0.0005).
Conclusion: This study showed that Alfuzosin in combination with Tolterodine was superior to Alfuzosin alone in patients with BPH having irritative (overactive bladder) symptoms.

Key words: Benign prostatic hyper- plasia, overactive bladder, lower urinary tract symptoms, bladder outflow obstruction, alpha-blocker, alfuzosin, antimuscarinic agent, tolterodine.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Imran Memon
Articles by Atif Javed
Articles by Abdul Jabbar Pirzada
Articles by Aziz Abdullah
Articles by Sajid Ali
Articles by Syed Farhan Ahmed
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Memon I, Javed A, Pirzada AJ, Abdullah A, Ali S, Ahmed SF. Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.. RMJ. 2014; 39(4): 421-424.


Web Style

Memon I, Javed A, Pirzada AJ, Abdullah A, Ali S, Ahmed SF. Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.. https://www.rmj.org.pk/?mno=161474 [Access: June 24, 2026].


AMA (American Medical Association) Style

Memon I, Javed A, Pirzada AJ, Abdullah A, Ali S, Ahmed SF. Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.. RMJ. 2014; 39(4): 421-424.



Vancouver/ICMJE Style

Memon I, Javed A, Pirzada AJ, Abdullah A, Ali S, Ahmed SF. Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.. RMJ. (2014), [cited June 24, 2026]; 39(4): 421-424.



Harvard Style

Memon, I., Javed, . A., Pirzada, . A. J., Abdullah, . A., Ali, . S. & Ahmed, . S. F. (2014) Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.. RMJ, 39 (4), 421-424.



Turabian Style

Memon, Imran, Atif Javed, Abdul Jabbar Pirzada, Aziz Abdullah, Sajid Ali, and Syed Farhan Ahmed. 2014. Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.. Rawal Medical Journal, 39 (4), 421-424.



Chicago Style

Memon, Imran, Atif Javed, Abdul Jabbar Pirzada, Aziz Abdullah, Sajid Ali, and Syed Farhan Ahmed. "Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.." Rawal Medical Journal 39 (2014), 421-424.



MLA (The Modern Language Association) Style

Memon, Imran, Atif Javed, Abdul Jabbar Pirzada, Aziz Abdullah, Sajid Ali, and Syed Farhan Ahmed. "Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.." Rawal Medical Journal 39.4 (2014), 421-424. Print.



APA (American Psychological Association) Style

Memon, I., Javed, . A., Pirzada, . A. J., Abdullah, . A., Ali, . S. & Ahmed, . S. F. (2014) Efficacy of Alfuzosin with or without Tolterodine, in men with Benign Prostatic Hyperplasia (BPH) having irritative (overactive bladder) symptoms.. Rawal Medical Journal, 39 (4), 421-424.